Can the use of varenicline improve the efficacy of pharmacotherapy for nicotine addiction?

Current Problems of Psychiatry

Soroka Ewelina¹  Skoczeń Nikodem¹  Olajossy Marcin¹  Masternak Sebastian²  Pająk Michał²  Mazur Rafał² 

[1] II Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin;Student Scientific Association by the II Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin;

关键词: smoking cessation;    nicotine replacement therapy;    varenicline;    bupropion;    cytisine;   

DOI  :  10.2478/cpp-2019-0002

来源: DOAJ

【 摘 要 】

Introduction: Smoking is a huge medical and social problem in Poland, with as many as about 24% of Poles being addicted to nicotine. Approximately 6 million people worldwide die every year from conditions that are closely related to tobacco addiction, such as cancer and cardiovascular, metabolic or lung diseases. The difficulty in combatting nicotine dependence is largely due to the complex mechanism of this addiction. The motivation of a patient to quit smoking is of great importance in the difficult withdrawal process. Strengthening this motivation is one of the most important tasks of physicians and addiction therapists.

【 授权许可】

Unknown